[1]
“Efficacy of Tocilizumab in the Treatment of Systemic Onset Juvenile Idiopathic Arthritis”, Bangladesh J Child Health, vol. 39, no. 3, pp. 129–134, Feb. 2017, doi: 10.3329/bjch.v39i3.31577.